<DOC>
	<DOC>NCT03020368</DOC>
	<brief_summary>In this trial the investigators want to prove the efficacy and safety of a one-time topical leech application at patients with symptomatic primary arthrosis of the first carpometacarpal joint in comparison to the standard therapy with topical diclofenac.</brief_summary>
	<brief_title>Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint</brief_title>
	<detailed_description />
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Male and female patients aged 35 to 85 years Pain intensity in the region of the thumb base in pain phases ≥ 40 mm on the VAS of 0 to 100 mm (relative to the last 24 hours) Complaints for at least 3 months Xray Stadium Eaton IIV at least once secured Anticoagulation (Marcumar, Heparin) Haemophilia, V. Willebrandt Jürgens syndrome, thrombocytopathy and other blood anomalies Combination therapy of ASA and thienopyridines Pain medication with opioid analgesics Systemic medication with corticoids or immunosuppressants Intraarterticular injections or RSO within the last 3 months Past or planned surgery on the affected joint in the next 2 months Pregnancy, lactation Insulindependent type I diabetes mellitus Acute psychotic disorders Severe comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>